| Literature DB >> 29505317 |
Jianwei Yuan1, Guoying Ni2, Tianfang Wang3, Kate Mounsey2, Shelley Cavezza2, Xuan Pan1, Xiaosong Liu1,2.
Abstract
Genital warts are one of the most common sexually transmitted diseases worldwide. The disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 and 11. Current therapies for genital warts are mainly ablative, or alternatively topical application of imiquimod cream and sinecatechin (polyphenon E) ointment to the warts. However, low patient compliance and high recurrence rate are significant problems for the treatment of genital warts by imiquimod and ablative therapies. We summarise recent literature in this area and propose combining imiquimod with other therapies to increase the efficacy of imiquimod.Entities:
Keywords: early protein 7; genital warts; imiquimod; interleukin 10
Mesh:
Substances:
Year: 2018 PMID: 29505317 PMCID: PMC6067868 DOI: 10.1080/21645515.2018.1445947
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452